@Naughty Morty ....
Yes there were a lot of congratulations given so I am assuming some big surprises from the announcement ....
Similar deals in Japan and Korea are under discussion.
Yes and SI was all over it (as you would expect I guess) ... Hong Kong was also discussed as it is believed to be the most advanced in Cardio ??
SI said that they have been in discussions with Tasly for a long time, so this paragraph that has been included on the foot of Quarterly reports that so many have complained about is now validated
Mesoblast is in advanced negotiations with selected pharmaceutical companies with respect to potential partnering of certain Tier 1 product candidates. If Mesoblast enters into a binding transaction in the next quarter, it expects that one effect of the transaction is that its cash reserves are likely to increase. Mesoblast does not make any representation or give any assurance that such a binding transaction will be concluded.
Also interesting to note that the deal is not subject to the success of the upcoming LVAD trial results being announced this quarter
@Naughty Morty .... Yes there were a lot of congratulations...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.29 |
Change
0.005(0.39%) |
Mkt cap ! $1.467B | |||
| Open | High | Low | Value | Volume |
| $1.29 | $1.31 | $1.27 | $1.653M | 1.285M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 16781 | $1.28 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.29 | 9777 | 1 |
View Market Depth
| Last trade - 16.10pm 05/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |